Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients.

Por Sluiters, J F, Balk, A H, Essed, C E, Mochtar, B, Weimar, W, Simoons, M L, Ijzerman, E P
Publicado em 1989

Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy.

Por de Leeuw, N, Melchers, W J, Ruiter, D J, Caforio, A L, Balk, A H, de Jonge, N, Galama, J M
Publicado em 1999

Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the blood.

Por Vaessen, L M, Baan, C C, Ouwehand, A J, Jutte, N H, Balk, A H, Mochtar, B, Claas, F H, Weimar, W
Publicado em 1992

Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants.

Por Baan, C C, van Emmerik, N E, Balk, A H, Quint, W G, Mochtar, B, Jutte, N H, Niesters, H G, Weimar, W
Publicado em 1994

T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantation

Por Vaessen, L M B, Daane, C R, Maat, A P W M, Balk, A H M M, Claas, F H J, Weimar, W
Publicado em 1999

The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease

Por Van Besouw, N M, Loonen, E H M, Vaessen, L M B, Balk, A H M M, Claas, F H J, Weimar, W
Publicado em 1998

Development of the Rotterdam Quality of Life Questionnaire for Heart Transplant Recipients

Por de Jeu, J.H., Pedersen, S.S., Balk, A.H.M.M., van Domburg, R.T., Vantrimpont, P.J.M.J., Erdman, R.A.M.
Publicado em 2003

Cardiac allograft vasculopathy in Dutch heart transplant recipients

Por Galli, G., Caliskan, K., Balk, A. H. M. M., van Domburg, R., Birim, O., Salerno-Uriarte, J., Manintveld, O. C., Constantinescu, A. A.
Publicado no Neth Heart J (2016)

Dronedarone in patients with atrial fibrillation

Por de Groot, N.M.S., Kirchhof, C.J., van Gelder, I.C., Meeder, J.G., Balk, A.H.M.M., Wilde, A.A., Simoons, M.L.
Publicado em 2010

The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell...

Por Jutte, N H, Groeneveld, K, Balk, A H, Ouwehand, A J, Loonen, E H, Van der Linden, M, Strikwerda, S, Mochtar, B, Claas, F H, Weimar, W
Publicado em 1994

Changes in left ventricular function and wall thickness in heart transplant recipients and their relation to acute rejection: an assessment by digitised M mode echocardiography

Por Mannaerts, H F J, Balk, A H M M, Simoons, M L, Tijssen, J, van der Borden, S G, Zondervan, P, Sutherland, G R, Roelandt, J R T C
Publicado em 1992

Intragraft interleukin 2 mRNA expression during acute cellular rejection and left ventricular total wall thickness after heart transplantation

Por de Groot-Kruseman, H A, Baan, C C, Hagman, E M, Mol, W M, Niesters, H G, Maat, A P, Zondervan, P E, Weimar, W, Balk, A H
Publicado em 2002

The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation

Por van Besouw, N M, Zuijderwijk, J M, Vaessen, L M B, Balk, A H M M, Maat, A P W M, van der Meide, P H, Weimar, W
Publicado em 2005

Cardiac sarcoidosis: Case-studies and a brief review of the literature

Por Smedema, J.P., Zondervan, P.E., van Hagen, P., ten Cate, F.J., Bresser, P., Doubell, A.F., Pattynama, P., Hoogsteden, H.C., Balk, A.H.M.M.
Publicado em 2002

Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood.

Por Hendriks, G. F., van Steenberge, E. P., Schreuder, G. M., Wenting, G. J., Mochtar, B., Bos, E., Simoons, M. L., Balk, A. H., Laird-Meeter, K., Essed, C. E.
Publicado em 1988

The avidity of allospecific cytotoxic T lymphocytes (CTL) determines their cytokine production profile

Por VAN EMMERIK, N E M, DAANE, C R, KNOOP, C J, HESSE, C, VAESSEN, L M B, BALK, A H M M, MOCHTAR, B, CLAAS, F H J, WEIMAR, W
Publicado em 1997

Heart transplantation in the Netherlands: quo vadis?

Por Kirkels, J.H., de Jonge, N., Klöpping, C., Lahpor, J.R., van Herwerden, L.A., Balk, A.H.M.M., Bogers, A.J.J.C., Maat, A.P.W.M., Doevendans, P.A.F.M.
Publicado em 2006

Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy

Por Otten, E., Lekanne dit Deprez, R.H., Weiss, M.M., van Slegtenhorst, M., Joosten, M., van der Smagt, J.J., de Jonge, N., Kerstjens-Frederikse, W.S., Roofthooft, M.T.R., Balk, A.H.M.M., van den Berg, M.P., Ruiter, J.S., van Tintelen, J.P.
Publicado em 2010

Guidelines for heart transplantation

Por de Jonge, N., Kirkels, J.H., Klöpping, C., Lahpor, J.R., Caliskan, K., Maat, A.P.W.M., Brügemann, J., Erasmus, M.E., Klautz, R.J.M., Verwey, H.F., Oomen, A., Peels, C.H., Golüke, A.E.J., Nicastia, D., Koole, M.A.C., Balk, A.H.M.M.
Publicado em 2008